Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dense Breasts”

133 trials

Showing 20 of 133 results

Testing effectiveness (Phase 2)UnknownNCT02059876
What this trial is testing

Dose-dense (Biweekly) Carboplatin Plus Paclitaxel With or Without Trastuzumab as Neoadjuvant Treatment for Breast Cancer

Who this might be right for
Breast Cancer
Guangdong Provincial People's Hospital 60
Not applicableStudy completedNCT03698942
What this trial is testing

Delphinus SoftVue™ ROC Reader Study

Who this might be right for
Breast CancerBreast Neoplasms
Delphinus Medical Technologies, Inc. 6
Not applicableActive Not RecruitingNCT03607552
What this trial is testing

Non-contrast DWI for Supplemental Screening

Who this might be right for
Breast Cancer
University of Washington 269
Not applicableStudy completedNCT00615901
What this trial is testing

Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 38
Not applicableUnknownNCT00436709
What this trial is testing

Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 75
Not applicableStudy completedNCT01236781
What this trial is testing

Comparison of Full-Field Digital Mammography With Digital Breast Tomography for Screening Call-Back Rates

Who this might be right for
Breast Neoplasms
American College of Radiology 558
Not applicableStudy completedNCT03257839
What this trial is testing

Delphinus SoftVue Prospective Case Collection - ARM 1

Who this might be right for
Breast Neoplasms
Delphinus Medical Technologies, Inc. 7,409
Not applicableUnknownNCT02066142
What this trial is testing

Tomosynthesis (TS) Versus Ultrasonography (US) in Women With Dense Breast

Who this might be right for
Breast Cancer
University of Genova 4,000
Not applicableStudy completedNCT00639535
What this trial is testing

Study Comparing the PET Scan and MRI in Identifying Breast Malignancies in Women With Breast Abnormalities

Who this might be right for
Breast Disease
State University of New York - Upstate Medical University 56
Not applicableLooking for participantsNCT06512350
What this trial is testing

Identifying Patterns in the Breath of Individuals With Breast Cancer

Who this might be right for
Breast Cancer
Breathe BioMedical Inc 1,000
Testing effectiveness (Phase 2)Study completedNCT01328249
What this trial is testing

Dose Dense Doxorubucin and Cyclophosphamide Followed by Eribulin Mesylate for the Adjuvant Treatment of Early Stage Breast Cancer

Who this might be right for
HER2-normal
Eisai Inc. 81
Very early researchStudy completedNCT00722059
What this trial is testing

Detection and/or Evaluation of Dense Breast Abnormalities Using Tomosynthesis and Digital Mammography

Who this might be right for
Breast NeoplasmsBreast Abnormalities
University of Michigan 50
Testing effectiveness (Phase 2)Ended earlyNCT00470249
What this trial is testing

Carboplatin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
University of Southampton 5
Not applicableStudy completedNCT01588834
What this trial is testing

Histology of Functional Density in Premenopausal Breast

Who this might be right for
Dense BreastsBreast Cancer
Mayo Clinic 23
Testing effectiveness (Phase 2)Study completedNCT01671319
What this trial is testing

Dose Dense TC + Pegfilgrastim Support for Breast Cancer

Who this might be right for
Female Breast Cancer
University of Wisconsin, Madison 42
Testing effectiveness (Phase 2)Study completedNCT00261313
What this trial is testing

ACCELERATE: Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Pegfilgrastim and Darbepoetin Alfa Support for the Treatment of Women With Breast Cancer

Who this might be right for
Breast Cancer
Amgen 80
Not applicableStudy completedNCT02995980
What this trial is testing

Study of Dual-energy (DE) Contrast-enhanced (CE) Digital Mammography

Who this might be right for
Breast Cancer
University of Alabama at Birmingham 128
Not applicableStudy completedNCT00991263
What this trial is testing

Study of Tissue Samples From Women Treated With Paclitaxel for Breast Cancer on Clinical Trial CALGB-9344 or CALGB-9741

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 3,677
Not applicableLooking for participantsNCT06322888
What this trial is testing

Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)

Who this might be right for
Breast CancerBreast Cancer Female
Dana-Farber Cancer Institute 46
Testing effectiveness (Phase 2)UnknownNCT00378638
What this trial is testing

Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymph Node Positive Breast Cancer: A Pilot Study

Who this might be right for
Breast Cancer
Chap, Linnea I., M.D. 30
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation